Cambridge biotech Generate Biomedicines said Thursday it has raised $370 million in enterprise capital from buyers eager on its plan To make the most of machine studying in drug discovery, money Which will allow the startup to increase its workforce Greater than sixfold.
Generate, which was based in 2018 by enterprise capital agency Flagship Pioneering, has about 80 staff at 26 Landsdowne St. and expects To lease some 420 extra Inside The subsequent two years, Based mostly on prime executives. The agency plans To maneuver quickly To 2 new buildings, totaling 140,000 sq. ft, in Andover and Somerville.
Unlock This textual content material by subscribing to STAT+ And luxuriate in your first 30 days free!
GET Started
What’s it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, coverage, and life science safety and evaluation.
Our award-worthwhile group covers information on Wall Road, coverage developments in Washington, early science breakthroughs and medical trial outcomes, and well being care disruption in Silicon Valley and past.
What’s included?
- Daily reporting and evaluation
- In all probability the most full enterprise safety from a powerhouse group of reporters
- Subscriber-solely informationletters
- Daily informationletters to short-term you on An important enterprise information of the day
- STAT+ Conversations
- Weekly alternatives To work together with our reporters and main enterprise speciaitemizings in stay video conversations
- Unique enterprise occasions
- Premium entry to subscriber-solely networking occasions Throughout the nation
- Definitely one of the biggest reporters Inside the enterprise
- In all probability the most trusted and properly-related informationroom Inside the well being care enterprise
- And a lot extra
- Unique interviews with enterprise leaders, profiles, and premium devices, like our CRISPR Trackr.